Pennsylvania 2025_0 Regular Session Status: In Committee Bipartisan · 4 R · 3 D cosponsors

HB 2646 — An Act amending the act of May 17, 1921 (P.L.682, No.284), known as The Insurance Company Law of 1921, in quality health care accountability and protection, further providing for medical policies and clinical review criteria.

Last action — Referred to INSURANCE, June 17, 2026

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the House. Introduced June 17, 2026. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the House.

Prognosis

Advancing 42% · moderate confidence

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

  • In Committee

    Current position in the legislative process.

  • 7 sponsors

    1 primary, 6 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (4 R · 3 D) — cross-party backing.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

In plain language

The bill aims to amend health insurance policies regarding FDA accelerated approval drugs.

This bill seeks to update existing insurance regulations to improve accountability and protection for medical services. It specifically addresses provisions related to drugs approved through the FDA's accelerated process.

What this means for you
  • Consumers: Consumers may see greater availability of certain FDA-approved drugs through their insurance plans.
  • Healthcare: This may lead to changes in how health insurers cover FDA accelerated approval drugs, potentially improving access for patients.

Summary

Protect Access to FDA Accelerated Approval Drugs

Bill Text

How this bill changes current law

1 change Share ↗

AI-generated reading aid from the bill's amendatory text — verify against the official bill.

The bill adds a requirement that insurers cannot exclude coverage for certain FDA-approved drugs based on their approval process.

  • Section 2154(b)(1)

    (v) Not exclude, restrict or delay coverage of a prescription drug solely on the basis that the drug was approved by the United States Food and Drug Administration pursuant to 21 U.S.C. § 356(c) (relating to expedited approval of drugs for serious or life-threatening diseases or conditions).

    This change ensures that insurers must provide coverage for drugs approved through expedited processes for serious conditions.

Action History

  1. Referred to INSURANCE, June 17, 2026

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 6 co-sponsors · 246 not signed on

Sponsors (1)

Co-sponsors (6)

Not signed on (246)

246 members have not signed on to this bill.

Show all 246 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 2646 do?
Protect Access to FDA Accelerated Approval Drugs
Who sponsors HB 2646?
HB 2646 is sponsored by Catherine I Wallen (Republican), Andrew Kuzma (Republican), Nathan Davidson (Democratic), Brenda M. Pugh (Republican), Benjamin V. Sanchez (Democratic), John C. Inglis III (Democratic), and Andrea C. Verobish (Republican).
What is the current status of HB 2646?
This bill is in committee in the House. Introduced June 17, 2026. It must pass committee before a floor vote.
Where can I track HB 2646?
Track HB 2646 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 2646

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 2646

Last checked for changes 4 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →